A Comparative Genomic Study in Schizophrenic and in Bipolar Disorder Patients, Based on Microarray Expression Profiling Meta-Analysis

Schizophrenia affecting almost 1% and bipolar disorder affecting almost 3%–5% of the global population constitute two severe mental disorders. The catecholaminergic and the serotonergic pathways have been proved to play an important role in the development of schizophrenia, bipolar disorder, and oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Logotheti, Marianthi, Papadodima, Olga, Venizelos, Nikolaos, Chatziioannou, Aristotelis, Kolisis, Fragiskos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608181/
https://www.ncbi.nlm.nih.gov/pubmed/23554570
http://dx.doi.org/10.1155/2013/685917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608181/
https://www.ncbi.nlm.nih.gov/pubmed/23554570
http://dx.doi.org/10.1155/2013/685917

Ejemplares similares